SG11202103490RA - Galactose oral composition and use thereof - Google Patents

Galactose oral composition and use thereof

Info

Publication number
SG11202103490RA
SG11202103490RA SG11202103490RA SG11202103490RA SG11202103490RA SG 11202103490R A SG11202103490R A SG 11202103490RA SG 11202103490R A SG11202103490R A SG 11202103490RA SG 11202103490R A SG11202103490R A SG 11202103490RA SG 11202103490R A SG11202103490R A SG 11202103490RA
Authority
SG
Singapore
Prior art keywords
oral composition
galactose oral
galactose
composition
oral
Prior art date
Application number
SG11202103490RA
Inventor
Oliver Yoa-Pu Hu
Ping Yang
Cheng-Huei Hsiong
Original Assignee
Avalon Hepapoc Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avalon Hepapoc Ltd filed Critical Avalon Hepapoc Ltd
Publication of SG11202103490RA publication Critical patent/SG11202103490RA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/08Hepato-biliairy disorders other than hepatitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Pathology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG11202103490RA 2018-10-19 2018-10-19 Galactose oral composition and use thereof SG11202103490RA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2018/111079 WO2020077632A1 (en) 2018-10-19 2018-10-19 Galactose oral composition and use thereof

Publications (1)

Publication Number Publication Date
SG11202103490RA true SG11202103490RA (en) 2021-05-28

Family

ID=70284403

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11202103490RA SG11202103490RA (en) 2018-10-19 2018-10-19 Galactose oral composition and use thereof
SG11202102697XA SG11202102697XA (en) 2018-10-19 2018-10-19 Galactose oral composition and use thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11202102697XA SG11202102697XA (en) 2018-10-19 2018-10-19 Galactose oral composition and use thereof

Country Status (10)

Country Link
EP (1) EP3866762A4 (en)
JP (1) JP2022505270A (en)
KR (1) KR20210102188A (en)
AU (2) AU2018445495A1 (en)
BR (1) BR112021007021A2 (en)
CA (1) CA3115851A1 (en)
EA (1) EA202190761A1 (en)
PH (2) PH12021550610A1 (en)
SG (2) SG11202103490RA (en)
WO (1) WO2020077632A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544954B1 (en) * 2002-02-19 2003-04-08 Oliver Yoa-Pu Hu Stable galactose injection solutions
US20040087514A1 (en) 2002-09-06 2004-05-06 Hughes Thomas E Nutritional compositions
WO2006060936A1 (en) * 2004-12-10 2006-06-15 Jacov Biotech Co. The method of blood sample for liver function test and the sample paper
CN103391781A (en) * 2011-04-20 2013-11-13 国防教育研究基金会 New low side effect pharmaceutical composition containing antituberculosis drugs
KR101743421B1 (en) * 2015-10-16 2017-06-05 고려대학교 산학협력단 Anticariogenic use of 3,6-anhydro-L-galactose

Also Published As

Publication number Publication date
BR112021007021A2 (en) 2021-07-13
EP3866762A1 (en) 2021-08-25
EA202190761A1 (en) 2021-08-03
PH12021550610A1 (en) 2021-10-04
AU2018445495A1 (en) 2021-04-15
WO2020077632A1 (en) 2020-04-23
EP3866762A4 (en) 2022-06-01
AU2023201158A1 (en) 2023-04-06
SG11202102697XA (en) 2021-04-29
JP2022505270A (en) 2022-01-14
CA3115851A1 (en) 2020-04-23
PH12021550776A1 (en) 2021-12-13
KR20210102188A (en) 2021-08-19

Similar Documents

Publication Publication Date Title
IL279897A (en) Fusosome compositions and uses thereof
SG11202011015QA (en) Fusosome compositions and uses thereof
IL260718B (en) Oral care compositions and methods of using the compositions
IL279755A (en) Senolytic compositions and uses thereof
ZA202005143B (en) Oral formulations and uses thereof
SG11202107687VA (en) Prebiotic composition and its use
IL279877A (en) Ivosidenib forms and pharmaceutical compositions
IL277663A (en) Erenumab compositions and uses thereof
GB201807576D0 (en) Compositions and uses thereof
IL285916A (en) Novel compositions and use thereof
ZA202104261B (en) Combination pharmaceutical compositions and methods thereof
GB201901413D0 (en) Compositions and their use
GB2573649B (en) Pharmaceutical compositions and associated kits and uses
SG11202103490RA (en) Galactose oral composition and use thereof
GB201821138D0 (en) Compositions and uses thereof
GB201812334D0 (en) Compositions and uses thereof
GB201907591D0 (en) Composition and use
GB201815215D0 (en) Composition and use
IL257226A (en) Inverse-freezing compositions and use thereof
GB202101543D0 (en) Vaping e-liquid composition and the use thereof
IL282671A (en) Therapeutic methods and compositions
GB201917989D0 (en) Compositions and medical uses
GB201815546D0 (en) Composition and uses thereof
GB201805096D0 (en) Composition and uses thereof
GB201816605D0 (en) New formulations and uses thereof